Source:http://linkedlifedata.com/resource/pubmed/id/18330476
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-3-11
|
pubmed:abstractText |
Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2 (Tie2) has been considered as a rational target for gene therapy in solid tumors. In order to identify a novel peptide ligand of Tie2 for targeted gene therapy, we screened a phage display peptide library and identified a candidate peptide ligand NSLSNASEFRAPY (designated GA5). Binding assays and Scatchard analysis revealed that GA5 could specifically bind to Tie2 with a dissociation constant of 2.1x10(-8)M. In addition, we showed that GA5 was internalized into tumor cells highly expressing Tie2. In the biodistribution assay, (125)I-GA5 was mainly accumulated in SPC-A1 xenograft tumors that express Tie2. In gene delivery studies, GA5-conjugated polyethylenimine vector could achieve greater transgene transduction than non-targeted vectors both in vitro and in vivo. Tumor growth inhibition was observed in SPC-A1 xenograft-bearing mice that received eight intratumoral injections of GA5-polyethylenimine/p53 complexes in 3 weeks. The difference in tumor volume between the experiment and control groups was significant (P<0.05). Our results showed that GA5 is a potentially efficient targeting element for cancer gene or molecular therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1745-7270
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-25
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18330476-Animals,
pubmed-meshheading:18330476-Cell Line, Tumor,
pubmed-meshheading:18330476-Female,
pubmed-meshheading:18330476-Gene Targeting,
pubmed-meshheading:18330476-Gene Therapy,
pubmed-meshheading:18330476-Humans,
pubmed-meshheading:18330476-Liver Neoplasms,
pubmed-meshheading:18330476-Mice,
pubmed-meshheading:18330476-Mice, Inbred BALB C,
pubmed-meshheading:18330476-Mice, Nude,
pubmed-meshheading:18330476-Peptides,
pubmed-meshheading:18330476-Receptor, TIE-2,
pubmed-meshheading:18330476-Tissue Distribution,
pubmed-meshheading:18330476-Tretoquinol,
pubmed-meshheading:18330476-Tumor Suppressor Protein p53
|
pubmed:year |
2008
|
pubmed:articleTitle |
Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.
|
pubmed:affiliation |
Department of Medical Oncology, Cancer Hospital of Fudan University, Shanghai 200032, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|